← Market

Rx · Drug

Drug card for a generic or brand name: RxNorm concept (RxCUI, ingredients, brands); one openFDA label (brand checked against RxNorm ingredients, else single-ingredient full prescribing info, most common route, earliest NDA/BLA) with clipped boxed warning, indications, dosing, contraindications, warnings, interactions, pregnancy, lactation, special-formulation flag, other routes, DailyMed link; DEA schedule and status (NDC data); FDA shortage and 2-year recall summaries.

GET https://api.kit-rx.com/v1/rx/drug

0.02 USDC on Base · payTo 0xAf8E0A8a8A0A8f65831b2dD0FFe0c1B804698D70

Status: verified · payable

Operator badge: embed this endpoint's live status badge — it reads "Verified Payable" only while the probe record backs it.

Settlement: direct to the seller's payTo — 0% HIVE402 take

Payment routes

Base · 0.02 USDC · payTo 0xAf8E0A8a8A0A8f65831b2dD0FFe0c1B804698D70 · via cdp · settles direct
Polygon · 0.02 USDC · payTo 0xAf8E0A8a8A0A8f65831b2dD0FFe0c1B804698D70 · via cdp · settles direct
Arbitrum · 0.02 USDC · payTo 0xAf8E0A8a8A0A8f65831b2dD0FFe0c1B804698D70 · via cdp · settles direct
Avalanche · 0.02 USDC · payTo 0xAf8E0A8a8A0A8f65831b2dD0FFe0c1B804698D70 · via cdp · settles direct
eip155:1329 · 0.02 0xe15f… · payTo 0xAf8E0A8a8A0A8f65831b2dD0FFe0c1B804698D70 · via cdp · settles direct
{
  "name": "Vyvanse"
}
{
  "attribution": [
    "This product uses …"
  ],
  "generated_at": "2026-11-13T21:50:07.688Z",
  "notes": [
    "Informational summary of …"
  ],
  "query": {
    "name": "Vyvanse"
  },
  "result": {
    "dea_schedule": "CII",
    "dea_schedule_status": "controlled",
    "label": {
      "application_number": "NDA021977",
      "brand_name": "Vyvanse",
      "generic_name": "LISDEXAMFETAMINE DIMESYLATE",
      "manufacturer": "Takeda Pharmaceuticals …",
      "other_routes": [],
      "pharm_class_epc": [],
      "pharm_class_moa": [],
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "special_formulation": null
    },
    "recalls": {
      "count": 9,
      "from": "2024-11-13",
      "match_basis": "product description …",
      "months": 24,
      "most_recent": [
        {}
      ],
      "to": "2026-11-13"
    },
    "rxnorm": {
      "brand_names": [
        "Vyvanse"
      ],
      "ingredients": [
        {}
      ],
      "name": "Vyvanse",
      "rxcui": "711043",
      "tty": "BN"
    },
    "shortages": {
      "counts_by_status": {
        "current": 90,
        "resolved": 0,
        "to_be_discontinued": 0
      },
      "current": [
        {}
      ],
      "in_shortage": true,
      "match_basis": "shortage generic name …",
      "products": [
        "Lisdexamfetamine …"
      ]
    }
  },
  "sources": [
    {
      "name": "NLM RxNorm (RxNav REST API)",
      "url": "https://lhncbc.nlm.nih.gov/RxNav/APIs/RxNormAPIs.html"
    }
  ]
}

Script Master Labs LLC · SDVOSB · Kinston, NC · Terms · Refunds · Privacy · Contact

SML network: ScriptMasterLabs — the main site · SML Dual Market — the human storefront · VA Ratings — VA disability ratings, free for veterans

Agent intel trust badge

Trust score67 / 100 · breakdown
Probe uptime (30d)100.0% over 1 probes · daily
Avg 402 latency658 ms
Paid calls (30d, on-chain)9 calls · 2 buyers · shared price cohort of 5
Facilitator-reported (30d)1 calls · 1 payers (CDP Bazaar)

How to call

GET https://api.kit-rx.com/v1/rx/drug · input in query · spec from live-challenge

Input schema
{
  "type": "object",
  "properties": {
    "name": {
      "type": "string",
      "description": "Generic or brand drug name, e.g. lipitor, metformin, Eliquis, amoxicillin clavulanate, Tylenol #3. A route or formulation word (oral, iv,...",
      "examples": [
        "Vyvanse"
      ]
    }
  },
  "required": [
    "name"
  ],
  "additionalProperties": false
}
Output schema
{
  "type": "object"
}
curl -i -X GET 'https://api.kit-rx.com/v1/rx/drug?name=Vyvanse'

Agents: POST https://hive402.scriptmasterlabs.com/mcp → route_task / proxy_call · SDK /sdk/hive402.mjs

Try it (your wallet signs; HIVE402 never holds funds)